Domain EYEION.com for sale! This premium domain is available now at Kadomain.com

Common arthritis drug found to lower blood pressure and risk of heart disease

  • medicalxpress.com language
  • 2025-09-03 20:18 event
  • 2 weeks ago schedule
Common arthritis drug found to lower blood pressure and risk of heart disease
Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.

1.099. Study shows lack of 'me time' for new mothers

  • 2 weeks ago schedule
  • medicalxpress.com language

New mothers only have approximately one hour out of their waking day for rest, according to new research published in the British Journal of Psychology.

1.100. England moves to ban sale of energy drinks to children

  • 2 weeks ago schedule
  • medicalxpress.com language

High-caffeine energy drinks such as Red Bull will be banned for sale to youths under 16 in England under plans announced by the government on Wednesday.

1.101. SeeMe detects hidden signs of consciousness in brain injury patients

  • 2 weeks ago schedule
  • medicalxpress.com language

SeeMe, a computer vision tool tested by Stony Brook University researchers, was able to detect low-amplitude, voluntary facial movements in comatose acute brain injury patients days before clinicians could identify overt responses.

1.102. New policy review highlights the importance of health-related quality of life in advanced cancer

  • 2 weeks ago schedule
  • medicalxpress.com language

A new policy review published in The Lancet Oncology and led by Ian Tannock and Madeline Pe, together with an international team of oncologists, statisticians, patients and patient-reported outcomes (PRO) experts from Common Sense Oncology (CSO) and the European Organization for Research and Treatment of Cancer (EORTC), emphasizes the critical role of health-related quality of life (HRQoL) data in the evaluation of treatments for people with advanced cancer.

1.103. Nasal mask support improves breathing in preterm babies in clinical trial

  • 2 weeks ago schedule
  • medicalxpress.com language

Using a nasal mask instead of a traditional face mask to support very premature babies at birth can significantly reduce the need for rescue breathing and escalation of care, a world-first trial led by researchers at Monash University's School of Clinical Sciences at Monash Health, in collaboration with Hudson Institute of Medical Research and Monash Children's Hospital (Monash Health), has shown.

1.104. As Republicans spar over IVF, some turn to obscure MAHA-backed alternative

  • 2 weeks ago schedule
  • medicalxpress.com language

Republican support for in vitro fertilization, after surging in the wake of a 2024 Alabama Supreme Court decision that threatened the procedure, may be splintering as President Donald Trump retreats from his IVF promises and more far-right voices gain ground.

1.105. Massachusetts reports first West Nile virus case in a human in 2025

  • 2 weeks ago schedule
  • medicalxpress.com language

A woman in her 70s has been infected with West Nile virus in Middlesex County, the Massachusetts Department of Public Health reported on September 2nd, marking the state's first human case of the mosquito-borne disease this year.

1.106. Bay Area doctor pursues cure for chronic hepatitis B as prevention falters

  • 2 weeks ago schedule
  • medicalxpress.com language

Liver specialist Maurizio Bonacini is in the race for a cure for hepatitis B, one of the world's most widespread diseases and a top cause of liver cancer around the globe.

1.107. Study suggests link between hepatitis B immunity and lower risk of developing diabetes

  • 2 weeks ago schedule
  • medicalxpress.com language

New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Diagnostics shows that people with hepatitis B immunity induced by vaccination have a lower risk of developing diabetes of any kind.

1.108. Common arthritis drug found to lower blood pressure and risk of heart disease

  • 2 weeks ago schedule
  • medicalxpress.com language

Methotrexate, a common medication used to treat rheumatoid arthritis, has a newly recognized useful secondary effect of lowering blood pressure and potentially reduces the risk of heart disease in people with this condition.

1.109. Shampoo-like gel could help chemo patients keep their hair

  • 2 weeks ago schedule
  • medicalxpress.com language

Cancer fighters know that losing their hair is often part of the battle, but Michigan State University researchers have developed a shampoo-like gel that has been tested in animal models and could protect hair from falling out during chemotherapy treatment.

1.110. 117 Western Australia vape sellers close up shop, but convenience stores still break the rules

  • 2 weeks ago schedule
  • medicalxpress.com language

New research shows that dedicated vape retail stores in Western Australia (WA) have become extinct since new national federal vaping legislation was introduced last year. But with researchers identifying that many convenience stores continue to break the rules, experts say ongoing monitoring and stricter enforcement is needed.

1.111. Artificially sweetened beverage consumption lifts gestational diabetes risk

  • 2 weeks ago schedule
  • medicalxpress.com language

Pregnant women who consume five or more drinks of artificially sweetened beverages (ASB) a week increase their risk of developing gestational diabetes by 6%, new research from the University of Adelaide has found.

1.112. Obtaining prefrontal cortex biopsies during deep brain stimulation adds no risk to procedure, study finds

  • 2 weeks ago schedule
  • medicalxpress.com language

Obtaining prefrontal cortex biopsies during deep brain stimulation (DBS) surgery in living patients does not increase the risk of adverse events or cognitive decline compared to standard DBS procedures that don't involve biopsies, a team of clinical research scientists at the Icahn School of Medicine at Mount Sinai has demonstrated.

1.113. Affordable, accessible, online pain management program developed

  • 2 weeks ago schedule
  • medicalxpress.com language

Providing an online program to help those living with persistent pain could remove barriers to accessing help, a University of Otago—Ōtākou Whakaihu Waka-led study has found.

1.114. A serotonin shield rather than a source: Revisiting the placenta's critical role in the health of babies

  • 2 weeks ago schedule
  • medicalxpress.com language

The placenta has long been thought to produce serotonin during pregnancy. But in a new study, Yale researchers shatter the deep-rooted hypothesis—and show that the placenta doesn't produce serotonin but instead regulates its delivery to the embryo and fetus. They found that serotonin comes from the pregnant parent, with the placenta acting as a "serotonin shield" that controls how much reaches the embryo and fetus.

1.115. Member States review the draft Global Action Plan on Antimicrobial Resistance

  • 2 weeks ago schedule
  • emro.who.int language

3 September 2025, Cairo, Egypt – In response to the urgent – and  growing ­– threat antimicrobial resistance (AMR) poses to global health, development and security, the World Health Organization (WHO) is developing a new Global Action Plan on AMR (AMR GAP 2.0) in line with Resolution WHA77.6 and the 2024 UN Political Declaration on AMR. As part of the process of framing the future of global AMR policy, the WHO Regional Office for the Eastern Mediterranean convened a consultation with Member States this week to review and provide feedback on the zero draft of the new plan. The consultation seeks to ensure that regional perspectives, priorities and challenges are reflected in the global strategy. In her opening remarks to health leaders from across the Region who gathered in Cairo for the event, Regional Director for the Eastern Mediterranean Dr Hanan Balkhy called for a technically robust, operationally practical and socially equitable plan that addresses the social determinants and gender dimensions of AMR and ensures that the Region’s needs are fully reflected in Read more...

1.116. New, 'off-the-shelf' immunotherapy shows promise for treating high-risk childhood leukemia

  • 2 weeks ago schedule
  • medicalxpress.com language

Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukemia.

1.117. Pancreatic insulin disruption triggers bipolar disorder-like behaviors in mice, study shows

  • 2 weeks ago schedule
  • medicalxpress.com language

Bipolar disorder is a psychiatric disorder characterized by alternating episodes of depression (i.e., low mood and a loss of interest in everyday activities) and mania (i.e., a state in which arousal and energy levels are abnormally high). On average, an estimated 1–2% of people worldwide are diagnosed with bipolar disorder at some point during their lives.

Cookie Policy

We use cookies and similar technologies to help the site provide a better user experience. By using the website you agree to our Cookie Policy, Terms of Use and Privacy Policy.